## TSN: Tyson Foods, Inc. - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 0.33 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-4.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($54.16)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. TYSON FOODS, INC. SEC 10-K Report**
- Source: TradingView | 20251203T193657 | Somewhat-Bearish | Relevance: 100%
- Tyson Foods, Inc. has released its fiscal 2025 Form 10-K report, detailing a 2.1% sales increase driven by higher prices in Beef, Pork, and Prepared Foods, despite a decrease in net income due to legal contingencies and goodwill impairments. The company is implementing a network optimization plan, expanding product offerings, and managing capital through stock repurchases and debt restructuring to navigate a dynamic market and address operational, international, and commodity price risks.

**2. Tyson Foods chairman sells $5.8m in class A common stock**
- Source: Investing.com | 20251201T133100 | Neutral | Relevance: 100%
- John H. Tyson, Chairman of Tyson Foods, sold 100,301 shares of Class A Common Stock for over $5.8 million, while also exercising options to acquire additional shares. These transactions occurred as the stock trades near $58.37, with analysis suggesting it may be undervalued. The company recently reported strong Q4 2025 earnings but missed revenue expectations and is closing a significant beef processing plant.

**3. Tyson Foods (TSN): Evaluating Valuation After Beef Business Restructuring and Facility Closures**
- Source: Sahm | 20251203T020950 | Somewhat-Bullish | Relevance: 100%
- Tyson Foods is undergoing significant restructuring in its beef business, including facility closures and operational streamlining, leading to a 13.4% share price increase over the last month. While a popular valuation narrative suggests the stock is 7% undervalued with a fair value of $62.67, driven by expected earnings momentum, another perspective questions this due to a high P/E ratio of 43.4x compared to industry averages. Investors are advised to consider both the potential for growth from operational efficiencies and the risks posed by cattle supply shortages and high valuation multiples.

**4. Tyson Foods (TSN) Chairman John H. Tyson exercises options and sells 100K+ shares**
- Source: Stock Titan | 20251202T060901 | Neutral | Relevance: 100%
- John H. Tyson, Chairman of the Board and director of Tyson Foods, Inc. (TSN), exercised 109,202 non-qualified stock options at $50 per share and subsequently sold 100,301 Class A Common shares at $58.05 per share on November 28, 2025. Following these transactions, he beneficially owns 2,989,415.464 Class A Common shares directly and no longer holds the reported stock options. This activity was reported in a high-impact and very positive sentiment SEC Form 4 filing.

**5. Tyson Foods chairman sells $5.8m in class A common stock By Investing.com**
- Source: Investing.com South Africa | 20251201T203200 | Neutral | Relevance: 100%
- John H. Tyson, Chairman of the Board at Tyson Foods Inc., sold 100,301 shares of Class A Common Stock for over $5.8 million while also exercising options to acquire an additional 109,202 shares. This transaction occurred amidst recent company developments, including exceeding fourth-quarter EPS estimates despite a revenue miss, and the closure of a beef processing plant in Nebraska. Analysts have adjusted price targets for Tyson Foods, maintaining "Market Perform" ratings and viewing the plant closure as a strategic move to improve industry margins.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | BMO Capital | $56 | $53 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 15 ($5.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.1%)
- Blackrock Inc.: 9.2% (-1.7%)
- State Street Corpora: 5.0% (+0.6%)
- Pzena Investment Man: 4.9% (+0.9%)
- Davis Selected Advis: 3.5% (+11.2%)

### Key Risks

1. Insider selling cluster: $5.8M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.33 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.7B |
| Beta | 0.46 |
| 52W Range | $50.56 - $64.36 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.33 |
| Forward P/E | 13.1 |
| Current P/E | 14.8 |
| YoY Growth | 12.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 7.1% to 2.3% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.7pp (needs >4.0% for momentum thesis). MRS_5 (-1.7%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.31% (CS: 73) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | 0.35 | Bullish |
| vs SMA20 | 1.035x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 1.008x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $56.78
- **Stop Loss:** $54.16 (4.6% risk)
- **Target:** $62.02 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 362
- **Position Value:** $20,554.36
- **Portfolio %:** 20.55%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-02 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $1.15 | +37.8% |
| 2025Q2 | $0.78 | $0.91 | +16.2% |
| 2025Q1 | $0.82 | $0.92 | +12.2% |
| 2024Q4 | $0.88 | $1.14 | +29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*